Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-60,615
Closed -$4.58M 508
2026
Q1
$4.58M Buy
60,615
+1,928
+3% +$145K 0.03% 406
2025
Q4
$4.37M Buy
58,687
+2,197
+4% +$161K 0.03% 414
2025
Q3
$3.81M Buy
56,490
+2,019
+4% +$134K 0.03% 421
2025
Q2
$3.55M Buy
54,471
+2,933
+6% +$176K 0.03% 418
2025
Q1
$3.18M Buy
51,538
+1,176
+2% +$77.9K 0.03% 424
2024
Q4
$3.63M Buy
50,362
+3,046
+6% +$238K 0.03% 394
2024
Q3
$3.85M Buy
47,316
+2,843
+6% +$227K 0.04% 374
2024
Q2
$3.3M Buy
44,473
+3,172
+8% +$238K 0.04% 373
2024
Q1
$3.22M Sell
41,301
-1,599
-4% -$119K 0.04% 366
2023
Q4
$3.07M Buy
42,900
+89
+0.2% +$6.2K 0.04% 368
2023
Q3
$2.97M Buy
42,811
+13,676
+47% +$1.03M 0.05% 340
2023
Q2
$2.36M Buy
29,135
+89
+0.3% +$7.27K 0.05% 326
2023
Q1
$2.34M Sell
29,046
-176
-0.6% -$14.2K 0.06% 318
2022
Q4
$2.19M Buy
29,222
+209
+0.7% +$14.9K 0.06% 331
2022
Q3
$1.87M Buy
+29,013
New +$2.01M 0.05% 342

Other funds holding HOLX

Czech National Bank's HOLX Position: Q2 2026 in Review

Czech National Bank sold out of Hologic (HOLX) in Q2 2026, closing a stake of 60,615 shares — an estimated $4.58M sold.

Czech National Bank first reported a position in HOLX in Q3 2022 and held it in 15 quarters. The position peaked at $4.58M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Czech National Bank reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Czech National Bank sold 60,615 Hologic shares in Q2 2026, an estimated $4.58M.
  • Czech National Bank first reported a position in Hologic in Q3 2022 and held it in 15 quarters.
  • Czech National Bank's Hologic position peaked at $4.58M in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.